Savencia (SAVE) AI Stock Analysis

4 Followers

Savencia

(Paris:SAVE)

Select Model

Rating:58Neutral

Price Target:EUR 59.00▲(3.15% Upside)

Action:reiterated

Date:11/07/26

The score is primarily held back by weakening 2025 financial performance (lower revenue, margin compression, and weaker cash conversion), despite manageable leverage. Valuation is a positive offset (low P/E and a moderate dividend yield), while technical indicators are broadly neutral with a slightly weak longer-term trend.

Positive Factors

Resilient Gross MarginGross margin staying around 33–34% indicates Savencia has preserved substantial product-level economics despite recent pressure on revenue and operating profitability. This resilience can support recovery if volume, pricing, or product mix improves over the next several quarters.

Negative Factors

Revenue ContractionThe 2025 revenue decline interrupts Savencia’s prior multi-year growth pattern and indicates weaker demand, volume, mix, or pricing realization across its businesses. Sustained top-line contraction would limit operating leverage and make it harder to absorb costs or support investment.

Savencia (SAVE) vs. iShares MSCI France ETF (EWQ)

Market Cap: EUR 740.84M
Dividend Yield: 2.45%
Average Volume (3M): 930
Price to Earnings (P/E): 9.9
Beta (1Y): 0.26
Revenue Growth: -1.53%
EPS Growth: -12.97%
Country: France
Employees: 22,680
Sector: General
Sector Strength: 55
Industry: Packaged Foods

Savencia Business Overview & Revenue Model

Company Description

Savencia SA is a French-headquartered enterprise, established in 1956, specializing in the production of dairy items for both domestic and international markets. The company's product portfolio encompasses a diverse range of cheeses, along with butte...

How the Company Makes Money

Savencia makes money mainly by selling dairy products—especially cheese—through a mix of branded retail sales and specialty/foodservice channels. A major revenue stream comes from consumer-facing packaged products sold via supermarkets and other reta...

Savencia Financial Statement Overview

Summary

Mixed fundamentals: revenue rose over 2020–2024 but declined in 2025 (-2.8% YoY) alongside weaker profitability. Gross margin stayed resilient (~33–34%), yet net margin is very thin (~1.1% in 2025) with EBIT/EBITDA margin compression. Leverage is manageable (debt-to-equity ~0.74), but cash flow quality is a concern as operating cash flow fell and free cash flow weakened, with low cash conversion (FCF ~19% of net income in 2025).

Income Statement

56Neutral

Balance Sheet

62Positive

Cash Flow

50Neutral

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	7.05B	6.96B	7.14B	6.79B	6.55B	5.61B
Gross Profit	2.37B	2.36B	2.41B	2.21B	279.49M	291.00M
EBITDA	411.51M	405.54M	464.55M	412.74M	373.25M	372.31M
Net Income	73.67M	74.70M	106.97M	96.48M	68.05M	82.94M
Balance Sheet
Total Assets	5.68B	4.88B	4.95B	4.65B	4.58B	4.32B
Cash, Cash Equivalents and Short-Term Investments	726.99M	684.84M	753.34M	636.14M	572.63M	572.62M
Total Debt	1.70B	1.24B	1.21B	1.19B	1.08B	1.09B
Total Liabilities	3.53B	2.94B	2.96B	2.83B	2.76B	2.62B
Stockholders Equity	1.89B	1.68B	1.74B	1.58B	1.59B	1.48B
Cash Flow
Free Cash Flow	75.17M	59.45M	138.77M	81.70M	66.65M	72.36M
Operating Cash Flow	313.81M	313.85M	386.89M	260.61M	255.05M	301.79M
Investing Cash Flow	-559.64M	-427.70M	-243.88M	-236.29M	-196.95M	-230.59M
Financing Cash Flow	216.95M	-108.28M	-10.74M	28.18M	-59.01M	-120.07M

Savencia Technical Analysis

Technical Analysis SentimentNeutral

Last Price57.20

Price Trends

50DMA57.22Negative

100DMA60.85Negative

200DMA61.76Negative

Market Momentum

MACD-0.00Negative

RSI53.08Neutral

STOCH66.67Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:SAVE, the sentiment is Neutral. The current price of 57.20 is above the 20-day moving average (MA) of 56.51, below the 50-day MA of 57.22, and below the 200-day MA of 61.76, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 53.08 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:SAVE.

Savencia Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

FR:SAVE against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:LOUP	72Outperform	EUR 3.94B	11.87	12.95%	2.06%	15.18%	31.78%
FR:BN	68Neutral	EUR 43.87B	22.31	11.34%	3.31%	0.46%	6.19%
FR:SAVE	58Neutral	EUR 781.76M	9.95	4.13%	2.45%	-1.53%	-12.97%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
FR:ALFLE	50Neutral	EUR 99.46M	10.21	7.40%	14.26%	4.46%	133.27%
FR:BON	44Neutral	EUR 294.23M	18.94	-3.09%	2.81%	-0.80%	―

* General Sector Average

Performance Comparison

FR:SAVE and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
FR:SAVE	Savencia SA	57.20	-1.47	-2.50%
FR:BON	Bonduelle SA	8.90	0.17	1.99%
FR:BN	DANONE SA	68.06	-7.83	-10.32%
FR:ALFLE	Fleury Michon	23.70	-0.41	-1.72%
FR:LOUP	Societe LDC Societe Anonyme	109.00	20.23	22.79%
FR:SABE	Saint Jean Groupe SA	22.20	1.60	7.77%

Savencia Corporate Events

Savencia Lifts Revenue on Chocolate Acquisitions Amid Weak Core Dairy Demand

Oct 14, 2026

Savencia reported revenue of €5.423 billion at end‑September 2026, up 7.8% year on year in reported data, driven largely by the consolidation of newly acquired Chocolate and Quata activities and the seasonal pickup in chocolate invoicing. Under compa...

Savencia’s Half-Year Results Show Acquisition-Driven Growth Amid Margin and Debt Pressures

Sep 10, 2026

Savencia reported first-half 2026 sales of €3.486 billion, up 2.6% year-on-year, driven by the integration of Savencia Gourmet’s chocolate business and Brazil’s Quata, even as like-for-like revenue declined due to pricing and weaker demand. Historica...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026

Savencia AI Stock Analysis